Filing Details

Accession Number:
0001562180-16-001291
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-07 16:54:45
Reporting Period:
2016-01-07
Filing Date:
2016-01-07
Accepted Time:
2016-01-07 16:54:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304815 Kimi Iguchi C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
Cfo, Secretary And Treasurer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-31 176 $49.56 84,739 No 5 P Direct
Common Stock Acquisiton 2016-01-07 4,000 $0.45 88,739 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-01-07 4,000 $0.00 4,000 $0.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
61,495 2023-08-12 No 4 M Direct
Footnotes
  1. Common shares acquired under the Company's Employee Share Purchase Plan (ESPP).
  2. The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option shall vest in full on August 12, 2017, subject to continued service through such date.